Changes in biomarkers of bone turnover in an aripiprazole add-on or switching study

Schizophrenia Research
Rohit J LodhiKatherine J Aitchison

Abstract

The association between mental illness and osteoporosis and fractures is particularly pronounced in psychotic disorders. Antipsychotic use has previously been described to affect bone density. A 52-week follow-up of patients switched to aripiprazole or with aripiprazole added on, conducting a specific analysis of markers of bone turnover: urinary NTX (a biomarker of bone resorption) and serum BSAP (a biomarker of bone formation). Baseline and serial measurements of bone markers NTX, BSAP and of hormones prolactin, oestrogen and testosterone were done at weeks 0 and 1, 2, 6, 12, 26 and 52, respectively. NTX concentration reduced over time but this did not reach significance in the whole group (log-NTX: β=-0.0012, p=0.142). For BSAP the addition of or replacement with aripiprazole produced a significant reduction (log-BSAP: β=-0.00039, p=0.002). Analysis with prolactin similarly showed a significant reduction (log-prolactin: β=-0.0024, p<0.001); other hormones did not change significantly. Sensitivity analysis to compare the switchers to aripiprazole versus the "add-on" showed that the former group had a significant reduction in NTX. We found that switching to aripiprazole was associated with changes in molecular biomarkers of bo...Continue Reading

References

May 18, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C P LawlerR B Mailman
Mar 1, 2003·Psychopharmacology·Daniel E CaseyUNKNOWN Aripiprazole Study Group
Jun 26, 2003·The Journal of Clinical Psychiatry·Scott W Woods
Jun 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·A M MeaneyV O'Keane
Dec 31, 2004·The American Journal of Psychiatry·Martina HummerW Wolfgang Fleischhacker
Jan 12, 2005·The Journal of Clinical Psychiatry·Madhusmita MisraAnne Klibanski
Feb 3, 2007·The British Journal of Psychiatry : the Journal of Mental Science·Louise HowardMorven Leese
Oct 9, 2007·Acta Psychiatrica Scandinavica·S LeuchtN Sartorius
Mar 1, 2008·Journal of Psychopharmacology·Amna MirKatherine J Aitchison
Jul 22, 2008·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Gioia Di GiovanniPanagiota Klentrou
Oct 23, 2008·Cleveland Clinic Journal of Medicine·Frederick R Singer, David R Eyre
Nov 19, 2008·Human Psychopharmacology·Purificación Rey-SánchezJuan D Pedrera-Zamorano
Jun 10, 2009·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·A L SchaferD C Bauer
Feb 24, 2010·Journal of Psychopharmacology·Katherine J AitchisonPaul McCrone
Dec 25, 2010·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S VasikaranUNKNOWN IOF-IFCC Bone Marker Standards Working Group
Dec 31, 2010·Journal of Clinical Psychopharmacology·James M BoltonWilliam D Leslie
Jan 22, 2011·Psychiatry Investigation·Tae-Young LeeHyung-Seok So
Mar 2, 2011·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J-J BodyJ-Y Reginster
Mar 8, 2011·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Marc DE HertStefan Leucht
Nov 23, 2011·Human Psychopharmacology·Norio SugawaraSunao Kaneko
Jun 30, 2012·Current Opinion in Psychiatry·Taishiro KishimotoChristoph U Correll
Feb 12, 2013·Clinical Schizophrenia & Related Psychoses·Bruce J KinonJayanthi Jacob
May 22, 2013·International Journal of Endocrinology·Haishan WuJindong Chen
Jul 13, 2013·Schizophrenia Research·Maxine X PatelThomas R E Barnes
Jun 1, 2012·Therapeutic Advances in Psychopharmacology·Jeffrey R BishopJohn A Sweeney
Aug 30, 2013·Journal of Translational Medicine·Gillian WheaterJacob M van Laar
Jul 12, 2014·The Journal of Clinical Endocrinology and Metabolism·Susan J DiemBenjamin Z Leder
Jul 22, 2014·Acta Psychiatrica Scandinavica·B StubbsD Vancampfort
Feb 11, 2015·General Hospital Psychiatry·Brendon StubbsDavy Vancampfort
Apr 5, 2015·Schizophrenia Bulletin·Stefan LeuchtJohn M Davis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.